FDA Approved: NIPENT — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Nipent (pentostatin) submitted by Hospira, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hairy Cell Leukemia

Drugs mentioned

• NIPENT (pentostatin)

Snippet

SUPPL AP for NIPENT (PENTOSTATIN)